-
Innovative Kidney Donor 'Voucher' System Is Saving Lives
drugs
June 25, 2021
In the world of chronic kidney disease, the dilemma is not uncommon: A relatively young patient with kidney trouble may need a transplant down the road, and an older family member is more than ready to step up. But the need for a kidney transplant.
-
Gene therapy successfully treats rare immunodeficiency in paediatric patients
europeanpharmaceuticalreview
May 13, 2021
In three Phase I/II trials an experimental gene therapy caused all but two patients with severe combined immunodeficiency to acquire and retain robust immune function for more than two years.
-
UCLA-led study identifies potential drug for Covid-19 treatment
pharmaceutical-technology
March 26, 2021
Researchers from the University of California, Los Angeles (UCLA) and universities in California, Delaware and Germany, as well as German company Merck, have identified a compound, berzosertib, which demonstrated potential in treating SARS-CoV-2 virus ...
-
Google hires Geisinger CEO as new health strategy leader
pharmaphorum
December 12, 2018
Google has hired Geisinger Health CEO David Feinberg to provide strategic leadership as the tech giant moves into the health sector.
-
Bloom bags cash, UCLA tech to treat epilepsy via the microbiome
fiercebiotech
May 29, 2018
Bloom Science has raised seed money and licensed technology to treat CNS diseases via the gut-brain axis. Building on research into the ketogenic diet, Bloom is initially focusing on developing bacterial treatments for epilepsy.